An Exploratory Study of Itolizumab on the Preservation of Beta Cell Function in Adults with Recent-Onset Type 1 Diabetes

We conducted a phase I-IIa, randomized, monocentric, double-blind, placebo-controlled clinical trial to evaluate the safety and impact of the combination treatment of Itolizumab and insulin on preserving beta cell function in adults with recent-onset type 1 diabetes. Twelve patients were randomly as...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera-Rode, Eduardo, Cubas-Dueñas, Ileana, Rodríguez-Acosta, Janet, García-García, Yudith, Torres-López, Yelena, Prieto-Noa, Claudia, Vázquez-Izada, Bárbara M., Ruíz-Reinoso, Maité, Echevarría-Valdés, Ragmila, Álvarez-Álvarez, Aimee, Domínguez-Alonso, Emma, Conesa-González, Ana Ibis, González-Calero, Teresa, Robles-Torres, Erick, Turcios-Tristá, Silvia Elena, Senra-Estévez, Elizabeth, Hernández-Casaña, Patricia, Sarmiento, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999981/
https://www.ncbi.nlm.nih.gov/pubmed/35407396
http://dx.doi.org/10.3390/jcm11071789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999981/
https://www.ncbi.nlm.nih.gov/pubmed/35407396
http://dx.doi.org/10.3390/jcm11071789

Ejemplares similares